Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

BACKGROUND: Magnetic resonance imaging (MRI) may guide breast cancer surgery by measuring residual tumor size post-neoadjuvant chemotherapy (NAC). Accurate measurement may avoid overly radical surgery or reduce the need for repeat surgery. This individual patient data (IPD) meta-analysis examines MR...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Marinovich, Michael L., Macaskill, Petra, Irwig, Les, Sardanelli, Francesco, Mamounas, Eleftherios, von Minckwitz, Gunter, Guarneri, Valentina, Partridge, Savannah C., Wright, Frances C., Choi, Jae Hyuck, Bhattacharyya, Madhumita, Martincich, Laura, Yeh, Eren, Londero, Viviana, Houssami, Nehmat
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599727/
https://ncbi.nlm.nih.gov/pubmed/26449630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1664-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires